RECURRENT/METASTATIC HEAD AND NECK SQUAMOUS CELL CARCINOMA
Clinical trials for RECURRENT/METASTATIC HEAD AND NECK SQUAMOUS CELL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new RECURRENT/METASTATIC HEAD AND NECK SQUAMOUS CELL CARCINOMA trials appear
Sign up with your email to follow new studies for RECURRENT/METASTATIC HEAD AND NECK SQUAMOUS CELL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Scientists test 'Smart Bomb' drug to fight tough head and neck cancers
Disease control Not yet recruitingThis study is testing a new type of targeted cancer drug, GSK5764227, for people with advanced head and neck cancer that has returned or spread. The drug works like a 'smart bomb' that seeks out cancer cells and delivers a chemotherapy agent directly to them. Researchers will giv…
Matched conditions: RECURRENT/METASTATIC HEAD AND NECK SQUAMOUS CELL CARCINOMA
Phase: PHASE2 • Sponsor: University Health Network, Toronto • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC
-
New hope for Tough-to-Treat head and neck cancers
Disease control Not yet recruitingThis study is testing a combination of three drugs (docetaxel, nimotuzumab, and pucotenlimab) for people with advanced head and neck cancer that has returned or spread after previous treatments failed. The goal is to see if this new combination can shrink tumors and control the d…
Matched conditions: RECURRENT/METASTATIC HEAD AND NECK SQUAMOUS CELL CARCINOMA
Phase: PHASE2 • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated Mar 24, 2026 12:02 UTC